A new research study conducted on patients enrolled in Illinois' pilot medical marijuana program has found that cannabis treatments have helped patients cut back on prescription drug use, or even quit entirely. Medical cannabis consulting firm Aclara Research recently released The Illinois Medical Cannabis Patient Experience Study, the first study on the effectiveness of the state's pilot MMJ program, which was launched in 2012.
A study of patients in Illinois suggests that CBD products are nearly as popular as THC products, and that women are the driving force behind sales of the former. The Illinois Medical Cannabis Patient Experience Study – conducted by Aclara Research, a Chicago medical marijuana patient research firm – found that 47% of patients said they use CBD daily and 22% had no previous experience with marijuana before joining the state’s MMJ program.
CHICAGO, May 23, 2017 (GLOBE NEWSWIRE) -- Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study - the first of Illinois patients since the inception of the pilot program in 2012. The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered.